Randox Showcases Extensive Range of Revolutionary Diagnostic Analyzers at MEDICA 2021
Posted on 16 Nov 2021
Randox Laboratories (Crumlin, UK) shared a wealth of new products and innovative technologies with the industry at the 2021 edition of MEDICA. More than 5,000 exhibitors from 70 countries presented their newest products and ideas at MEDICA which drew 120,000 trade visitors from over 170 countries.
At MEDICA 2021, Randox presented the Discovery benchtop lab, an exciting and disruptive molecular & immunoassay diagnostic analyzer capable of consolidating the normal workload of multiple laboratories, into one compact benchtop platform. Randox’s patented Biochip technology allows simultaneous detection of hundreds of targets from a single patient sample. The benefits of multiplexing in this way are endless; allows complete patient profiling, reduces the amount of time spent on individual tests, identifies co-infections, differentiates between pathogens that exhibit similar symptoms and eliminates the need to run multiple time consuming and sample intensive assays. The biochip detection system is based on a chemiluminescent signal, this is the emission of light, without heat, as a result of a chemical reaction.
Randox also showcased the RX misano semi-automated clinical chemistry analyzer that shines a new light on semi-automated clinical chemistry testing with increased auto-functionality and groundbreaking technology. Among other products exhibited at the event by Randox were the RX daytona+ fully automated analyzer that performs a wide range of niche and specialized routine chemistries, specific proteins, lipids, therapeutic drugs, antioxidants, diabetes and veterinary testing; and the RX monaco compact fully automated solution that comprises an extensive test menu covering routine chemistries, specific proteins, lipids, antioxidants, diabetes and veterinary testing with emergency and STAT sampling.
Among its extensive range of diagnostic tests, Randox highlighted its newly-launched Vivalytic Extensive SARS-CoV-2 pooling test which is a rapid real-time PCR test cartridge that provides clear and concise results in a timely manner, direct at the point of care on the Vivalytic instrument. The SARS-CoV-2 polling test with lollipop swab allows for the screening of up to 15 patient samples. One of the first rapid pooling PCR tests on the market, the Vivalytic produces results in less than 45 minutes delivering high accuracy for extensive and faster testing ideal for rapid and confirmatory SARS-CoV-2 screening in any environment.
Related Links:
Randox Laboratories
